Company news
Correvio Pharma Corp news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Cardiome Expands Partnership with Eddingpharm to Commercialize AGGRASTAT in China
August 24, 2015
United Kingdom Department of Health Sets BRINAVESS Pricing
August 10, 2015
Cardiome Reports Second Quarter 2015 Financial Results
August 5, 2015
Cardiome to Hold Second Quarter 2015 Financial Results Conference Call on August 5
July 28, 2015
Cardiome Partner Eddingpharm to Initiate BRINAVESS Phase I Study in China
July 24, 2015
Cardiome Submits Supplemental New Drug Submission (sNDS) For AGGRASTAT To Health Canada
July 22, 2015
Cardiome to Present at JMP Securities Healthcare Conference
June 16, 2015
Independent Study Finds Intravenous Vernakalant Facilitates Electrical Cardioversion in Patients with Cardioversion Resistant Atrial Fibrillation
June 12, 2015
Cardiome Appoints David Dean Vice President, Business Development and Investor Relations
June 3, 2015
Cardiome Reports First Quarter 2015 Financial Results
May 13, 2015
Cardiome and AOP Orphan Pharma Enter ESMOCARD Commercialization Agreement
May 12, 2015
Cardiome To Hold First Quarter 2015 Financial Results Conference Call On May 13
May 7, 2015
Cardiome to Present at Bloom Burton & Co. Healthcare Investor Conference
April 27, 2015
Cardiome Receives BRINAVESS Reimbursement Approval From Belgian Authorities
April 9, 2015
Cardiome reports fourth quarter and full year 2014 financial results
March 12, 2015
Cardiome to Hold Fourth Quarter and Full Year 2014 Financial Results Conference Call on March 12
March 5, 2015
Cardiome Enters Development and Commercialization Agreement with Eddingpharm for BRINAVESS(TM) in China
December 19, 2014
Cardiome Enters Commercialization Agreement with Aspen for BRINAVESS® in South Africa
November 17, 2014
Cardiome Submits BRINAVESS® Reimbursement Dossier to Italian Authorities to Support Market Access
November 7, 2014
Cardiome Reports Third Quarter 2014 Financial Results
November 7, 2014
Cardiome Announces Positive Results from the BRINAVESS® Asia-Pacific Phase 3 Clinical Trial
November 7, 2014
Cardiome to Hold Third Quarter 2014 Financial Results Conference Call on November 7
October 31, 2014
S&P Dow Jones Indices Announces Changes to the S&P/TSX Canadian Indices
September 12, 2014
Cardiome Enters Commercialization Agreement With Eurolab Especialidades Medicinales For BRINAVESS(TM) In Argentina
August 25, 2014
Cardiome Reports Second Quarter 2014 Financial Results
August 11, 2014
Cardiome Submits BRINAVESS Dossier to French Authorities to Support Market Access
August 6, 2014
Cardiome To Present At Canaccord Genuity Growth Conference On August 13
August 6, 2014
Cardiome Submits BRINAVESS Reimbursement Dossier to Belgian Authorities
August 5, 2014
Cardiome to hold second quarter 2014 financial results conference call on August 11
August 5, 2014
Cardiome announces closing of senior, secured term loan facility
July 18, 2014
Cardiome to Present at JMP Securities Healthcare Investor Conference
June 19, 2014
Cardiome to present at Bloom Burton & Co. Healthcare Investor Conference
June 11, 2014
Cardiome Announces Commercialization Partnership For AGGRASTAT® In Select European Markets
May 20, 2014
Cardiome Reports First Quarter 2014 Financial Results
May 12, 2014
Cardiome to hold first quarter 2014 financial results conference call on May 12
May 6, 2014
Cardiome Announces Commercialization Agreement With UDG Healthcare plc For BRINAVESS(TM) In Ireland
May 5, 2014
Cardiome Enters Agreement With Vianex S.A. To Commercialize BRINAVESS In Greece
March 28, 2014
Cardiome Reports Fourth Quarter and Full Year 2013 Financial Results
March 27, 2014
Cardiome To Hold Fourth Quarter And Full Year 2013 Financial Results Conference Call On March 27
March 20, 2014
Cardiome Enters Into an Agreement to Distribute BRINAVESS in Spain
March 19, 2014
Cardiome Closes C$30 Million Primary And Secondary Common Share Offering
March 11, 2014
Cardiome Announces C$30 Million Primary and Secondary Common Share Offering
February 20, 2014
Cardiome Announces Update in Commercialization Partnership for BRINAVESS(TM) in Select European Markets
February 19, 2014
Cardiome Enters BRINAVESS Distribution Agreement With Nomeco A/S In Denmark
February 18, 2014
Cardiome Announces At-The-Market Offering
February 18, 2014
Cardiome's BRINAVESS Demonstrates 74% Cardioversion in Post-Cardiac Surgery Patients with Atrial Fibrillation
February 13, 2014
Cardiome Enters Brinavess Distribution Agreement with Tamro AB in Sweden
February 11, 2014
Cardiome Announces Filing Of Shelf Prospectus And Registration Statement
January 30, 2014
Europace Publishes Data Supporting Use Of BRINAVESS(TM) (Vernakalant) As A First Line Agent For Pharmacological Cardioversion Of Atrial Fibrillation
November 21, 2013
Cardiome To Acquire Correvio LLC
November 18, 2013
Decks
- Q3 2019 Earnings Presentation
Earnings · 14 slides · Nov 14, 2019
- Investor Presentation (November 2019)
Investor deck · 14 slides · November 2019